Press Releases

KING OF PRUSSIA, PA - Aug 29, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced that it has been named to the 2018 Inc. 5000 list, an honor it has now earned six years in a row. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment- its independent small and midsized businesses.

Landing on the Inc. 5000 list for the sixth year in a row places Greenphire in the elite rarefied category shared by fewer than 6% of the companies that have ever been on the list.

“Our ability to sustain high growth over many years is a testament to our capability to solve difficult problems in the clinical trial process and to earn exceptional customer loyalty by delivering on our promises,” said Jim Murphy, CEO of Greenphire. “Greenphire’s technology solutions transform clinical trial payment processes enabling greater control, transparency, predictability and efficiency for all clinical research stakeholders. We are honored to once again be recognized by Inc. for our continued growth and success.”

Greenphire’s ClinCard is the industry standard in participant payment automation and has facilitated more than six million reimbursements to over one million clinical trial participants around the world, reducing administrative burden and improving participant retention. eClinicalGPS is the site payment software of choice for global sponsors and CROs looking to automate investigator grant payments enterprise-wide, optimizing clinical trial operations and enhancing financial transparency and control.

Greenphire will be honored at the 37th Annual Inc. 5000 Conference and Gala on October 17-19, 2018, at the JW Marriott Resort & Spa in San Antonio, Texas.

To learn more about Greenphire, please visit: www.greenphire.com.

About Greenphire

Greenphire is the global leader in clinical trial payment software. Greenphire is exclusively focused on optimizing clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. The choice of industry leaders worldwide, Greenphire supports site centricity and sustainability, increases patient engagement and retention, and provides more comprehensive financial data, resulting in better trials. Learn more at www.greenphire.com.